GILD240809C77000
- 0.01
- -0.96-98.97%
Gilead Sciences Newsroom
Express News | Cantor Fitzgerald Reiterates Neutral on Gilead Sciences, Maintains $70 Price Target
74 S&P 500 Stocks That Can Beat the Cash Yield - BofA
Express News | Gilead Sciences Shares Are Trading Lower. The Company Reported Q2 Financial Results
Gilead (GILD) Q2 Earnings Beat, Annual Profit Guidance Raised
Deutsche Bank Keeps Their Hold Rating on Gilead Sciences (GILD)
Express News | Gilead Sciences Inc. : Morgan Stanley Raises Target Price to $79.00 From $74.00
Gilead Sciences (GILD) Gets a Hold From Cantor Fitzgerald
Gilead Sciences: Hold Rating Affirmed Amid Mixed Performance and Cautious Outlook
Gilead Sciences Is Maintained at Outperform by BMO Capital
Gilead Sciences Analyst Ratings
Express News | Gilead : BMO Raises Target Price to $85 From $80
Morgan Stanley Raises Price Target on Gilead Sciences to $79 From $74, Keeps Equalweight Rating
Gilead Sciences Reports Net Income Rise in Q2 2024
Gilead Sciences Poised for Growth: A Strong Buy Rating With a $93 Price Target
These Stocks Are Moving the Most Today: Expedia, Paramount, E.l.f. Beauty, Doximity, Rocket Lab, Gilead, and More -- Barrons.com
Express News | Gilead : RBC Raises Target Price to $72 From $71
Gilead (GILD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Gilead Sciences | 10-Q: Q2 2024 Earnings Report
S&P 500 Tries Its Best to Rebound With Best Day In A Year | Wall Street Today
Gilead Sciences Posts Higher 2Q Profit, Revenue on Increased Sales